ClearBridge Small Cap Strategy adds KWR, RNA, exits SEAT, GDRX among Q3 moves
Source: SeekingAlpha
2025-10-15 12:18:25 ET
More on LXP Industrial Trust, Wabash National, etc.
- Freshpet: Still Barking At A Potential Bargain
- GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside
- CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic?
- GoodRx launches subscription program for men's hair loss
- ClearBridge SMID Cap Growth Strategy adds CRDO, RKLB, exits OSCR, RARE
Read the full article on Seeking Alpha
For further details see:
ClearBridge Small Cap Strategy adds KWR, RNA, exits SEAT, GDRX among Q3 moves
Ultragenyx Pharmaceutical Inc.
NASDAQ: RARE
RARE Trading
-2.02% G/L:
$21.37 Last:
483,687 Volume:
$21.93 Open:
RARE Latest News
RARE Stock Data
$2,352,123,132
91,171,303
0.09%
84
N/A
Biotechnology & Life Sciences
Healthcare
US
Novato
